RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - Patogenesi molecolare dei linfomi in funzione della terapia
• 2 - Identificazione, analisi molecolare ed attività funzionale di recettori di membrana e fattori citoplasmatici coinvolti nella crescita e differenziamento di cellule di leucemia linfatica cronica B: impatto sulla prognosi clinica.
• 3 - Nuove frontiere nella stratificazione delle leucemie acute linfoidi (LAL): integrazione tra citogenetica non-convenzionale, genomica e post-genomica
• 4 - Immunità umorale nella sclerosi multipla: attivazione dei linfociti B e demielinizzazione
• 5 - Patogenesi molecolare delle malattie del motoneurone come tool per l’identificazione di nuovi approcci terapeutici biomolecolari e cellulari
• 6 - Basi genetiche dell’autoimmunità: studi in modelli naturali di aumentata suscettibilità
• 7 - Eritropoiesi normale e patologica: caratterizzazione molecolare mediante tecnologie avanzate a resa elevata.
• 8 - Il fattore di trascrizione NF-kB nella regolazione del differenziamento ed apoptosi del sistema immune.
• 9 - PROGRESSIONE DA MGUS A MIELOMA MULTIPLO: PATOGENESI MOLECOLARE, IDENTIFICAZIONE DI POTENZIALI MARCATORI PROGNOSTICI E SVILUPPO PRECLINICO DI RAZIONALI APPROCCI CHEMIOPREVENTIVI
• 10 - Analisi genomica e funzionale delle cellule emopoietiche nelle malattie mieloproliferative croniche

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • MALATTIE DEL SANGUE

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)

Classificazione geografica

• Regione: Emilia Romagna

Bibliografia

Bichi, R., Shinton, S. A., Martin, E. S., et al (2002). Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci U S A 99, 6955-6960.

Buhl AM, Jurlander J, Jorgensen FS, et al Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemia.
Blood. 2006;107:2904-11.

Buhmann R, Kurzeder C, Rehklau J, et al CD40L stimulation enhances the ability of conventional metaphase cytogenetics to detect chromosome aberrations in B-cell chronic lymphocytic leukaemia cells.
Br J Haematol. 2002; 118:968-75.

Bullrich, F., Fujii, H., Calin, G., et al (2001). Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res 61, 6640-6648.

Bullrich, F., Veronese, M. L., Kitada, S., et al (1996). Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia. Blood 88, 3109-3115.

Burger JA, Burger M, Kipps TJ. Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood. 1999;94: 3658-67.

Byrd JC, Stilgenbauer S, Flinn IW. Chronic lymphocytic leukemia. Hematology (Am Soc Hematol Educ Program). 2004;163-83.

Calin, G. A., Dumitru, C. D., Shimizu, M., et al (2002). Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99, 15524-15529.

Calin, G. A., Liu, C. G., Sevignani, C., et al (2004a). MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A 101, 11755-11760.

Calin, G. A., Sevignani, C., Dumitru, C. D., et al (2004b). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101, 2999-3004.

Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med. 2005;352:804-15.

Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005;102:13944-9.

Cuneo, A., Bigoni, R., Negrini, M., et al (1997). Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation. Cancer Res 57, 1144-1150.

Cuneo A, Rigolin GM, Bigoni R, et al. Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis. Leukemia. 2004;18:476-483.

Dohner, H., Stilgenbauer, S., Benner, A., et al (2000). Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343, 1910-1916.

Dyer, M. J., and Oscier, D. G. (2002). The configuration of the immunoglobulin genes in B cell chronic lymphocytic leukemia. Leukemia 16, 973-984.

Dykxhoorn, D. M., Novina, C. D., and Sharp, P. A. (2003). Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 4, 457-467.

Ghia P, Caligaris-Cappio F. The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms. Adv Cancer Res. 2000;79:157-73.

Houbaviy, H. B., Murray, M. F., and Sharp, P. A. (2003). Embryonic stem cell-specific MicroRNAs. Dev Cell 5, 351-358.

Juliusson, G., and Merup, M. (1998). Cytogenetics in chronic lymphocytic leukemia. Semin Oncol 25, 19-26.

Kuroki, T., Trapasso, F., Yendamuri, S., et al . (2003). Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 63, 3724-3728.

Lanham S, Hamblin T, Oscier D, et al. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood. 2003; 101:1087-93.

Liu, C. G., Calin, G. A., Meloon, B. et al (2004). An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A 101, 9740-9744.

Liu, Y., Corcoran, M., Rasool, O., et al (1997). Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene 15, 2463-2473.

Mabuchi, H., Fujii, H., Calin, G., et al (2001). Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia. Cancer Res 61, 2870-2877.

Mackey JR, Galmarini CM, Graham KA, et al. Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations.
Blood. 2005;105:767-74.

Mayr C, Speicher MR, Kofler DM, et al. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia.
Blood. 2006;107:742-51.

Narducci, M. G., Pescarmona, E., Lazzeri, C., et al. (2000). Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues. Cancer Res 60, 2095-2100.

Pedersen IM, Kitada S, Leoni LM, et al. Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. Blood. 2002;100:1795-801.

Pekarsky, Y., Hallas, C., Isobe, M., et al (1999). Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes. Proc Natl Acad Sci U S A 96, 2949-2951.

Rosenwald A, Chuang EY, Davis RE, et al. Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response.
Blood. 2004;104:1428-34.

Schichman, S. A., Aplan, P. D., Neri, A., et al (eds). (1996). Molecular pathogenesis of T-cell lymphoma (London, Edward Arnold).

Stevenson FK, Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations from the B-cell receptor.
Blood.2004; 103:4389-95.

Stilgenbauer, S., Bullinger, L., Lichter, P. et al (2002). Chronic lymphocytic leukemia. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course. Leukemia 16, 993-1007.

Teitell, M., Damore, M. A., Sulur, G. G. et al (1999). TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues. Proc Natl Acad Sci U S A 96, 9809-9814.

Virgilio, L., Lazzeri, C., Bichi, R., et al (1998). Deregulated expression of TCL1 causes T cell leukemia in mice. Proc Natl Acad Sci U S A 95, 3885-3889.

Virgilio, L., Narducci, M. G., Isobe, M., et al (1994). Identification of the TCL1 gene involved in T-cell malignancies. Proc Natl Acad Sci U S A 91, 12530-.

Willis, T. G., Jadavel, D. M., Coignet, L. J. et al (1997). Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction. Blood 90, 2456-2464.

Willis, T. G., Zalcberg, I. R., Coignet, L. J. et al (1998). Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21. Blood 91, 1873-1881.

Zeng, Y., Yi, R., and Cullen, B. R. (2003). MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci U S A 100, 9779-9784.

Parole Chiave

LEUCEMIA LINFATICA CRONICA, LESIONI CITOGENETICO MOLECOLARI, GENI MICRO-RNA, MODELLO MURINO, INTERAZIONI CELLULA-CELLULA, LINFOCITI T, CHEMOCHINE, SEQUENZA GENI IMMUNOGLOBULINICI, VARIAZIONE INTRACLONALE